Hims & Hers rises as U.S. to allow compounding of six peptides

Hims & Hers (HIMS) stock rose after the U.S. announced plans to allow compounding pharmacies to manufacture six peptides temporarily. Read more here.

CryptoAlerta — análise de criptomoedas e mercado em tempo real